Dr. Stanley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 S Euclid Ave
Saint Louis, MO 63110Phone+1 314-747-3000Fax+1 314-747-4511
Education & Training
- Massachusetts General HospitalResidency, Internal Medicine, 1980 - 1983
- Harvard Medical SchoolClass of 1980
Certifications & Licensure
- MO State Medical License 1983 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 223 citationsMacrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin.Karel Otero, Isaiah R. Turnbull, Pietro Luigi Poliani, William Vermi, Elisa Cerutti
Nature Immunology. 2009-06-07 - 15 citationsProtective Immunity to Amebiasis: New Insights and New ChallengesSamuel L. Stanley
The Journal of Infectious Diseases. 2001-08-15 - 111 citationsVirulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expressionBrice Sperandio, Béatrice Regnault, Jianhua Guo, Zhi Zhang, Samuel L. Stanley
The Journal of Experimental Medicine. 2008-05-12
Press Mentions
- Boji Family $5M Donation Fuels Henry Ford Health and MSU PartnershipMay 29th, 2022
- Couch: Michigan State Can Lead by Requiring Fans at Spartan Stadium to Be VaccinatedAugust 10th, 2021
- MSU Mandates COVID-19 Vaccination for All Students, Staff and Faculty, Reimposes Indoor Mask-Wearing RequirementJuly 30th, 2021
- Join now to see all
Grant Support
- An Animal Biosafety Level 3 Laboratory For Stony Brook UniversityNational Center For Research Resources2010
- Overall Career DevelopmentNational Institute Of Allergy And Infectious Diseases2008
- Mrce For Biodefense And Emerging Infectious Diseases (Development Projects)National Institute Of Allergy And Infectious Diseases2008
- Mrce Administrative CoreNational Institute Of Allergy And Infectious Diseases2008
- Immunogenetics Of Smallpox VaccinationNational Institute Of Allergy And Infectious Diseases2008
- Mrce For Biodefense And Emerging Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2003–2008
- Molecular Dissection Of E. Histolytica PathogenesisNational Institute Of Allergy And Infectious Diseases1992–2008
- Structure-Function Of Entamoeba Alcohol Dehydrogenase 2National Institute Of Allergy And Infectious Diseases2002–2005
- Molecular Dissection Of E Histolytica PathogenesisNational Institute Of Allergy And Infectious Diseases1994–2004
- Entameba Histolytica Adh2--A New Target For Anti-Amebic TherapyNational Institute Of Allergy And Infectious Diseases1996–1998
- Protective Immunity To Entamoeba Histolytica InfectionNational Institute Of Allergy And Infectious Diseases1994–1998
- Human T-Cell Recognition Of E Histolytica AntigensFogarty International Center1993–1995
- Pauciclonal Immunity: Models For DiversificationNational Institute Of Allergy And Infectious Diseases1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: